Stay updated on XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.

Latest updates to the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry v3.5.4 is added to the study record history, replacing the previous v3.5.3 entry. This update records the latest revision of the page history.SummaryDifference0.1%

- Check17 days agoChange DetectedVersion 21 was added to the Record History on 2026-04-28. New items IPDSharing and Oversight were introduced under the Study Record Versions.SummaryDifference0.5%

- Check24 days agoChange DetectedThe Record History shows a new Revision: v3.5.3 entry, representing a minor update to the page's history and replacing the previous v3.5.2 entry.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded a new revision entry v3.5.2 to the history and removed v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedNew record-history entries show updated Study Status and Recruitment Status, reflecting recent changes to the trial’s progress. The latest version entry includes a new last update date and associated status details.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision history updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

Stay in the know with updates to XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.